Reach Us +1-504-608-239
Editor - Vineeta Sharma | . | 26625
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Vineeta Sharma

Vineeta Sharma
Vineeta Sharma
Principal Consultant,
Xpedite Pharma Solutions, CA


Dr. Vineeta Sharma is the Principal Consultant at Xpedite Pharma Solutions. Xpedite is a life
sciences consulting company dedicated to providing regulatory, clinical data management and
scientific writing support to advance treatment for diabetes, cancer and other metabolic
disorders. Dr. Sharma holds a PhD from AIIMS, New Delhi and postdoctoral training from
University of Michigan and UCSF Benioff Children’s Hospital Oakland. She has published several
peer-reviewed articles and book chapters in the field of metabolic disorders, obesity, diabetes,
hematology and gene therapy. Over the years her research was mainly focused on metabolic
disorders, gene therapy and biomarker discovery. Additionally, Dr. Sharma has also worked in
startups, mid-size and fortune 500 companies, and in the areas of R&D, project management,
product development, business development, regulatory affairs and clinical trial management.
She is an advisor and board of director of life sciences startups.

Research Interest

Dr. Sharma’s research interest lies in cancer research, cell and gene therapy, metabolic and cardiovascular disorders. She is an expert in clinical diagnostics and acts as a liaison between academic research and it’s therapeutic and industrial applications.